Jim Cramer voiced skepticism about Lululemon Athletica Inc.'s latest earnings, posting on X, "I don't know how LULU could be ...

A popular theory frequently utilized by technical analysts suggests U.S. stocks could be headed for one last leg higher over ...

Investors with a lot of money to spend have taken a bearish stance on Gilead Sciences GILD. And retail traders should know.

Seeking to “unlock substantial value,” Carronade Capital Management nominates four directors to Cannae’s board.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued ...

Fintel reports that on March 19, 2025, Oppenheimer downgraded their outlook for Jefferies Financial Group (NYSE:JEF) from ...

This integration reinforces Oppenheimer's commitment to offer tailored, comprehensive financial solutions by expanding access ...

KEY TAKEAWAYS Google parent Alphabet has struck a deal to buy cybersecurity startup Wiz for $32 billion in an all-cash ...

The current political and regulatory environment bodes well for hospice providers, leaders of VITAS said Monday.

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer ...

LONDON, March 12, 2025 /PRNewswire/ -- Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a ...